Skip to main content

Artificial Intelligence and Machine Learning for Digital Pathology

State-of-the-Art and Future Challenges

  • Book
  • © 2020

Overview

  • Digital pathology is a disruptive innovation that will markedly change health care in the next few years
  • Biobanks play a central role providing large collections of high-quality well-annotated samples and data
  • Future broad applications of Artificial Intelligence in digital pathology

Part of the book series: Lecture Notes in Computer Science (LNCS, volume 12090)

Part of the book sub series: Lecture Notes in Artificial Intelligence (LNAI)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 chapters)

Keywords

About this book

Data driven Artificial Intelligence (AI) and Machine Learning (ML) in digital pathology, radiology, and dermatology is very promising. In specific cases, for example, Deep Learning (DL), even exceeding human performance. However, in the context of medicine it is important for a human expert to verify the outcome. Consequently, there is a need for transparency and re-traceability of state-of-the-art solutions to make them usable for ethical responsible medical decision support. 
Moreover, big data is required for training, covering a wide spectrum of a variety of human diseases in different organ systems. These data sets must meet top-quality and regulatory criteria and must be well annotated for ML at patient-, sample-, and image-level. Here biobanks play a central and future role in providing large collections of high-quality, well-annotated samples and data. The main challenges are finding biobanks containing ‘‘fit-for-purpose’’ samples, providing quality related meta-data, gaining access to standardized medical data and annotations, and mass scanning of whole slides including efficient data management solutions.


Editors and Affiliations

  • Medical University of Graz, Graz, Austria

    Andreas Holzinger, Heimo Müller

  • University of Alberta, Edmonton, Canada

    Randy Goebel, Michael Mengel

Bibliographic Information

Publish with us